Todd Hicks, MD
Plastic and Reconstructive Surgery · Dayton, OHNPI 1326054073
Payments from drug & device makers
What this record shows
This record is dominated by education: $10,852 of the $15,459 with a category attached, or 70.2%. Acell, Inc. accounts for 70.2% of it on its own, with 15 other manufacturers making up the rest. Reporting peaked in 2019 at $11,105 and has fallen 63.0% since, to $4,107 in 2025.
Across 32 payments — averaging $483.10 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Acell, Inc.$11K
- Polynovo North America LLC$4K
- KCI USA, Inc.$122
- Medline Industries LP$103
- Sientra, Inc.$85
- Solventum Corporation$66
- plus $190 from 10 others
What the payments were for
- Consulting fees$3,00019%
- Travel & lodging$8716%
- Food & beverage$7365%
- Education$10,85270%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Acell, Inc. | 6 | $10,852 |
| Polynovo North America LLC | 5 | $4,041 |
| KCI USA, Inc. | 1 | $122 |
| Medline Industries LP | 1 | $103 |
| Sientra, Inc. | 4 | $85 |
| Solventum Corporation | 3 | $66 |
| AbbVie(2 entities) | 2 | $38 |
| Baxter Healthcare | 2 | $36 |
| Smith+Nephew | 1 | $31 |
| Covidien LP | 1 | $19 |
| Urgo Medical North America, LLC | 1 | $15 |
| Galderma Laboratories, L.p. | 1 | $14 |
| Integra Lifesciences Corporation | 1 | $12 |
| Musculoskeletal Transplant Foundation Inc. | 1 | $10 |
| Polarityte, Inc. | 1 | $8 |
| Kerecis Limited | 1 | $7 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Novosorb BTM$3,988
- VAC VERAFLO$122
- PREVENA$122
How this compares
$15,459 in reported general payments places this provider in the 85th percentile of 78 plastic and reconstructive surgery providers in Ohio.
See all plastic and reconstructive surgery providers in Ohio →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Doxycycline Hyclate | 174 | $1,381 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 109 | $589 |
| Ondansetron OdtOndansetron | 68 | $521 |
| Cephalexin | 62 | $380 |
| SsdSilver Sulfadiazine | 13 | $228 |
| Silver Sulfadiazine | 11 | $227 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 18 | $151 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 26 | $131 |
| Bacitracin-PolymyxinBacitracin/Polymyxin B Sulfate | 11 | $116 |
| Tramadol Hcl | 32 | $73 |
| Oxycodone Hcl | 13 | $62 |
| Triamcinolone Acetonide | 17 | $53 |
Paid to pharmacies, not to this prescriber.
Other plastic and reconstructive surgery in Dayton
- Christopher GordonDayton$3K
- Salim ManchoDayton$1K
- Michelle SieffertDayton$1K
- Christopher ReederDayton$1K
- Paul VanekMentor$91K
- Richard SimmanToledo$76K
- Sunishka WimalawansaBeavercreek$68K
- James GatherwrightCleveland$52K
- Matthew GoldschmidtIndependence$47K
- Katherine GrawePowell$44K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.